Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices

Published on November 21, 2019

Pneumococcal conjugate vaccine use in children has led to sharp declines in pneumococcal disease among adults and children.

Continue reading on website
Other news

EARLY RELEASE: Update: Interim Guidance for Health Care Providers for Managing Patients with Suspected E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, November 2019

November 19, 2019
As rates of influenza increase, providers evaluating patients with respiratory illnesses should ask them about e-cigarette, or vaping, product use.

EARLY RELEASE: Characteristics of E-cigarette, or Vaping, Products Used by Patients with Associated Lung Injury and Products Seized by Law Enforcement - Minnesota, 2018 and 2019

November 26, 2019
This report evaluated e-cigarette, or vaping, products used by e-cigarette, or vaping, product use-associated lung injury patients and products intended for the illicit market and seized by law enforcement.